Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Net Income (2018 - 2025)

Historic Net Income for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to -$3.9 million.

  • Regenerative Medical Technology's Net Income fell 34436.35% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 73.94%. This contributed to the annual value of -$5.6 million for FY2024, which is 2284.43% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Net Income is -$3.9 million, which was down 34436.35% from -$1.3 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Net Income peaked at $68663.0 during Q4 2022, and registered a low of -$9.9 million during Q3 2021.
  • For the 5-year period, Regenerative Medical Technology's Net Income averaged around -$1.5 million, with its median value being -$758890.0 (2025).
  • Per our database at Business Quant, Regenerative Medical Technology's Net Income soared by 10439.81% in 2022 and then tumbled by 39913110.6% in 2023.
  • Regenerative Medical Technology's Net Income (Quarter) stood at -$1.6 million in 2021, then surged by 104.4% to $68663.0 in 2022, then plummeted by 2675.25% to -$1.8 million in 2023, then soared by 63.86% to -$639071.0 in 2024, then crashed by 516.01% to -$3.9 million in 2025.
  • Its Net Income was -$3.9 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$758890.0 in Q1 2025.